Related references
Note: Only part of the references are listed.Hemostasis and cancer: Impact of haemostatic biomarkers for the prediction of clinical outcomes in patients with cancer
Florian Moik et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)
Venous thromboembolism in cancer patients: a population-based cohort study
F. Mulder et al.
BLOOD (2021)
Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysis
Ella Grilz et al.
EUROPEAN HEART JOURNAL (2021)
Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer
Florian Moik et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysis
Ella Grilz et al.
EUROPEAN HEART JOURNAL (2021)
Haemostatic biomarkers for prognosis and prediction of therapy response in patients with metastatic colorectal cancer
Florian Moik et al.
THROMBOSIS RESEARCH (2020)
Systemic Inflammation and Activation of Haemostasis Predict Poor Prognosis and Response to Chemotherapy in Patients with Advanced Lung Cancer
Florian Moik et al.
CANCERS (2020)
Association of programmed cell death ligand 1 and circulating lymphocytes with risk of venous thromboembolism in patients with glioma
Pegah Mir Seyed Nazari et al.
ESMO OPEN (2020)
Venous Thromboembolism in Brain Tumors: Risk Factors, Molecular Mechanisms, and Clinical Challenges
Julia Riedl et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)
Identification of a novel alternatively spliced isoform of antithrombin containing an additional RCL-like loop
Sayeed Ur Rehman et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
How I treat patients with hereditary antithrombin deficiency
Ingrid Pabinger et al.
BLOOD (2019)
Antithrombin levels are associated with the risk of first and recurrent arterial thromboembolism at a young age
F. Nanne Croles et al.
ATHEROSCLEROSIS (2018)
Frequency, risk actors, and impact on mortality of arterial thromboembolism in patients with cancer
Ella Grilz et al.
HAEMATOLOGICA (2018)
Risk of Venous Thrombosis in Antithrombin Deficiency: A Systematic Review and Bayesian Meta-analysis
F. Nanne Croles et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2018)
Frequency, risk actors, and impact on mortality of arterial thromboembolism in patients with cancer
Ella Grilz et al.
HAEMATOLOGICA (2018)
Cancer-associated venous thromboembolism: Burden, mechanisms, and management
Cihan Ay et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism
Julia Riedl et al.
BLOOD (2017)
Interaction of Hereditary Thrombophilia and Traditional Cardiovascular Risk Factors on the Risk of Arterial Thromboembolism Pooled Analysis of Four Family Cohort Studies
Bakhtawar K. Mahmoodi et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2016)
Interaction of Hereditary Thrombophilia and Traditional Cardiovascular Risk Factors on the Risk of Arterial Thromboembolism Pooled Analysis of Four Family Cohort Studies
Bakhtawar K. Mahmoodi et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2016)
Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS)
I. Pabinger et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas
Johannes Thaler et al.
NEURO-ONCOLOGY (2014)
Prediction of Venous Thromboembolism in Patients With Cancer by Measuring Thrombin Generation: Results From the Vienna Cancer and Thrombosis Study
Cihan Ay et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Laboratory tests for antithrombin deficiency
Bernard Khor et al.
AMERICAN JOURNAL OF HEMATOLOGY (2010)
Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives
Willem M. Lijfering et al.
BLOOD (2009)
D-Dimer and Prothrombin Fragment 1+2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study
Cihan Ay et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)
Cihan Ay et al.
BLOOD (2008)
Epidemiology of venous thromboembolism in 9489 patients with malignant glioma
Thomas J. Semrad et al.
JOURNAL OF NEUROSURGERY (2007)
Developmental haemostasis - Impact for clinical haemostasis laboratories
P Monagle et al.
THROMBOSIS AND HAEMOSTASIS (2006)
Share Paper
